About Codexis
Codexis is a company based in Redwood City (United States) founded in 2002.. Codexis has raised $74.17 million across 9 funding rounds from investors including Chevron, FirstMark and Maxygen. The company has 188 employees as of December 31, 2024. Codexis offers products and services including CodeEvolver Platform and ECO Synthesis Technology. Codexis operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Redwood City, United States
- Employees 188 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Codexis, Inc.
-
Annual Revenue
$59.34 M-15.39as on Dec 31, 2024
-
Net Profit
$-65.28 M14.38as on Dec 31, 2024
-
EBITDA
$-50.22 M-11.91as on Dec 31, 2024
-
Total Equity Funding
$74.17 M (USD)
in 9 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Jun 20, 2019
-
Investors
Chevron
& 7 more
-
Employee Count
188
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Codexis
Codexis is a publicly listed company on the NASDAQ with ticker symbol CDXS in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Codexis
Codexis offers a comprehensive portfolio of products and services, including CodeEvolver Platform and ECO Synthesis Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for tailoring enzyme performance in biocatalysis applications.
Technology for enzymatic processes in oligonucleotide production.
Unlock access to complete
Unlock access to complete
Leadership Team
20 people
Product Management Team
8 people
Software Development Team
8 people
Scientist Team
8 people
Sales and Marketing
6 people
Finance and Accounting
5 people
Human Resources and Administration
5 people
Principal Team
3 people
Unlock access to complete
Funding Insights of Codexis
Codexis has successfully raised a total of $74.17M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $50.0M
-
First Round
First Round
(04 Oct 2002)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Post-IPO - Codexis | Valuation |
investors |
|
| Jun, 2010 | Amount | Grant - Codexis | Valuation |
investors |
|
| Oct, 2007 | Amount | Series D - Codexis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Codexis
Codexis has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Chevron, FirstMark and Maxygen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Codexis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Codexis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Codexis Comparisons
Competitors of Codexis
Codexis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Codexis
Frequently Asked Questions about Codexis
When was Codexis founded?
Codexis was founded in 2002.
Where is Codexis located?
Codexis is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Codexis?
Stephen Dilly is the current CEO of Codexis.
Is Codexis a funded company?
Codexis is a funded company, having raised a total of $74.17M across 9 funding rounds to date. The company's 1st funding round was a Series D of $600K, raised on Oct 04, 2002.
How many employees does Codexis have?
As of Dec 31, 2024, the latest employee count at Codexis is 188.
What is the annual revenue of Codexis?
Annual revenue of Codexis is $59.34M as on Dec 31, 2024.
What does Codexis do?
Codexis was founded in 2002 and is headquartered in Redwood City, United States. Operations focus on biotechnology, where the proprietary CodeEvolver platform is used to identify and engineer novel enzymes for pharmaceutical manufacturing. Additional efforts include the development of biotherapeutics and the Enzyme-Catalyzed Oligonucleotide Synthesis platform for producing RNA oligonucleotide therapeutics. These activities support drug discovery and synthesis processes in the sector.
Who are the top competitors of Codexis?
What products or services does Codexis offer?
Codexis offers CodeEvolver Platform and ECO Synthesis Technology.
Is Codexis publicly traded?
Yes, Codexis is publicly traded on NASDAQ under the ticker symbol CDXS.
Who are Codexis's investors?
Codexis has 8 investors. Key investors include Chevron, FirstMark, Maxygen, Casdin Capital, and CMEA Capital.
What is Codexis's ticker symbol?
The ticker symbol of Codexis is CDXS on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.